4th World Congress: Rare Diseases and Orphan Products

11 – 12 June 2018

With the success from the previous Rare Diseases Congress-2017, Conference series LLC takes a lot of privilege in inviting all the participants from all over the world to attend “4th World Congress on Rare Diseases and Orphan Drugs, will be held during June 11-12, 2018 in Dublin, Ireland which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions related to Rare Diseases and Orphan Drugs. It serve as a bridge between researchers from academia and health care centres enhanced by its well organized scientific sessions, plenary lectures, poster presentations, world class exhibitions, diverse symposiums, highly enriched workshops and B2B meetings.

ConferenceSeries Ltd Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.

Rare Diseases Congress-2018 conduct presentations, distributes information, conducts meetings with current and potential scientists, make a splash with new drug developments, There are more than 6,8001 diseases classified as “rare”. While individually these entities are uncommon, as a group they are an important cause of chronic illness, disability and premature death in both children and adults. Rare Diseases meeting the academic and long-term research developments can be discussed enabling a comparison between different theories, concepts and approaches

Target Audience:

Pathologists
Infectious Diseases Specialists
Pharmacists
Epidemiologists
Health Care Professionals
Microbiologists

Finnstown Castle Hotel Newcastle Road Lucan Co. Dublin Dublin Ireland

Venue

Finnstown Castle Hotel
Newcastle Road
Lucan
Dublin
Ireland

The ERNs are co-funded by the
European Union (Health Programme and CEF)

EU Commission


“EURO-NMD is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. The ERNs are co-funded by the European Union (Health Programme and CEF).
For more information about the ERNs and the EU health strategy,
please visit ec.europa.eu/health/ern